These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7889948)

  • 1. Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients.
    Martino P; Girmenia C; Micozzi A; De Bernardis F; Boccanera M; Cassone A
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):797-804. PubMed ID: 7889948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution.
    Lass-Flörl C; Gunsilius E; Gastl G; Englisch M; Koch G; Ulmer H; Dierich MP; Petzer A
    Ann Hematol; 2003 Sep; 82(9):565-9. PubMed ID: 14504812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida colonization and systemic infection in neutropenic patients. A retrospective study.
    Martino P; Girmenia C; Venditti M; Micozzi A; Santilli S; Burgio VL; Mandelli F
    Cancer; 1989 Nov; 64(10):2030-4. PubMed ID: 2804891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
    DiNubile MJ; Hille D; Sable CA; Kartsonis NA
    J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
    Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
    Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of caspofungin and amphotericin B for invasive candidiasis.
    Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J;
    N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global distribution and outcomes for Candida species causing invasive candidiasis: results from an international randomized double-blind study of caspofungin versus amphotericin B for the treatment of invasive candidiasis.
    Colombo AL; Perfect J; DiNubile M; Bartizal K; Motyl M; Hicks P; Lupinacci R; Sable C; Kartsonis N
    Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):470-4. PubMed ID: 12884068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.
    Pachl J; Svoboda P; Jacobs F; Vandewoude K; van der Hoven B; Spronk P; Masterson G; Malbrain M; Aoun M; Garbino J; Takala J; Drgona L; Burnie J; Matthews R;
    Clin Infect Dis; 2006 May; 42(10):1404-13. PubMed ID: 16619152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
    Laverdière M; Rotstein C; Bow EJ; Roberts RS; Ioannou S; Carr D; Moghaddam N
    J Antimicrob Chemother; 2000 Dec; 46(6):1001-8. PubMed ID: 11102422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
    Winston DJ; Chandrasekar PH; Lazarus HM; Goodman JL; Silber JL; Horowitz H; Shadduck RK; Rosenfeld CS; Ho WG; Islam MZ; Buell DN
    Ann Intern Med; 1993 Apr; 118(7):495-503. PubMed ID: 8442620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
    Bannatyne RM; Cheng PC; Fong IW
    Infection; 1992; 20(3):168-70. PubMed ID: 1644494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
    Paterson PJ; McWhinney PH; Potter M; Kibbler CC; Prentice HG
    Br J Haematol; 2001 Jan; 112(1):175-80. PubMed ID: 11167799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.
    Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Ricci P; Carotenuto M; Liso V; Nosari AM; Barbui T; Fasola G; Mandelli F;
    Ann Intern Med; 1994 Jun; 120(11):913-8. PubMed ID: 8172437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of candidaemia among neutropenic patients treated for haematological diseases.
    Chryssanthou E; Kalin M; Engervall P; Petrini B; Björkholm M
    Scand J Infect Dis; 1998; 30(5):489-93. PubMed ID: 10066051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of systemic empirical treatment with amphotericin B to prevent candidemia in neutropenic patients with cancer.
    Blumberg EA; Reboli AC
    Clin Infect Dis; 1996 Mar; 22(3):462-6. PubMed ID: 8852963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
    Philpott-Howard JN; Wade JJ; Mufti GJ; Brammer KW; Ehninger G
    J Antimicrob Chemother; 1993 Jun; 31(6):973-84. PubMed ID: 8360134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
    Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
    J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibody-bearing liposomal amphotericin B in the treatment of systemic candidiasis in a neutropenic murine model.
    Belay T; Hospenthal DR; Rogers AL; Patterson MJ
    J Med Vet Mycol; 1991; 29(6):419-21. PubMed ID: 1815035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.